Literature DB >> 3139662

Agonist-induced down-regulation of the angiotensin II receptor in primary cultures of rat hepatocytes.

B Bouscarel1, P B Wilson, P F Blackmore, C J Lynch, J H Exton.   

Abstract

The ability of angiotensin II to down-regulate its receptor was tested on rat hepatocytes in primary culture for 4 h. Angiotensin II treatment decreased [3H]angiotensin II specific binding in a concentration- and time-dependent manner. The effect was maximum with 1 microM angiotensin II and after 2 h. There was a decrease in the maximum number of binding sites (56% of control) with no significant effect on the apparent dissociation constant. The down-regulation was blocked by the angiotensin II antagonist [Val4,Ile7]angiotensin III and was not induced by other hormones (e.g. vasopressin, norepinephrine, or glucagon) or by 4 beta-phorbol 12 beta-myristate 13 alpha-acetate or A23187 ionophore. The decrease in angiotensin II receptors resulted in correlated decreases in the potency of angiotensin II to activate phosphorylase or lower glucagon-induced cAMP accumulation. However, high concentrations of the agonist were still able to elicit maximal responses in both parameters. Down-regulation of the receptor was not dependent upon active Gi, since it was still observed after ADP-ribosylation and inactivation of Gi by pertussis toxin. The above results indicate that the down-regulation of the hepatic angiotensin II receptor induced by its agonist is homologous and does not involve Gi, Ca2+, or protein kinase C. The correlation of receptor loss with decreases in the potency of angiotensin to activate phosphorylase and inhibit glucagon-induced cAMP accumulation is consistent with the idea that a single receptor population regulates two different messengers, i.e. calcium and cAMP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34.

Authors:  Khuraijam Dhanachandra Singh; Sadashiva S Karnik
Journal:  Br J Pharmacol       Date:  2022-04-23       Impact factor: 9.473

2.  Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes.

Authors:  B Bouscarel; H Fromm; S Ceryak; M M Cassidy
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

3.  Angiotensin converting enzyme inhibition does not affect the response to exogenous angiotensin II in the human forearm.

Authors:  D Lyons; D Stewart; J Webster; N Benjamin
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

4.  Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens.

Authors:  C S Sum; D C Wan; W T Cheung
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Angiotensin converting enzyme inhibition does not affect response to exogenous angiotensin II in the forearm of mild-moderate hypertensive patients.

Authors:  D Lyons; J Webster; N Benjamin
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  A single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors.

Authors:  Matthew T Duvernay; Chunmin Dong; Xiaoping Zhang; Mélanie Robitaille; Terence E Hébert; Guangyu Wu
Journal:  Traffic       Date:  2009-02-11       Impact factor: 6.215

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.